Gastrointestinal Cancer News

The Perlmutter Cancer Center at NYU Langone Medical Center has launched their new Pancreatic Cancer Center, a multidisciplinary center to improve the diagnosis, treatment and prevention of pancreatic cancer, according to a press release.

Harry Staszewski, MD, has joined New York Cancer & Blood Specialists.

Weijing Sun, MD, has been appointed medical oncology division director and Sprint Foundation professor of medical oncology at University of Kansas School of Medicine and The University of Kansas Cancer Center.

Recently published data revealed a significant association between low lymphocyte infiltration in hepatocellular carcinoma tumors and higher recurrence rates and poor overall survival compared with high lymphocyte infiltration.

An FDA advisory committee today expressed unanimous support of ABP 215, a biosimilar candidate to bevacizumab.

A new biomarker panel accurately detected early stages of pancreatic ductal adenocarcinoma in human blood samples, according to new research.

Google search volume correlated with state-specific cancer incidence and mortality rates for melanoma and other common cancers, according to recently published study results in JAMA Dermatology.

NYU Langone’s Perlmutter Cancer Center launched a new program designed to identify, study and care for high-risk patients who have hereditary syndromes that increase cancer risk.

People are more likely to undergo colorectal cancer screening if their insurance policy covers computed tomographic colonography, according to new research.

The FDA granted orphan drug designation to entrectinib for the treatment of patients with NTRK fusion–positive solid tumors, according to the drug’s manufacturer.